INDEPENDENT CITIZENS' OVERSIGHT COMMITTEE ("ICOC")
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT
Date: February 10, 2006
Time: 8:30 AM-5:30 PM (Estimated)
- Stanford University
Arrillaga Alumni Center
326 Galvez Street
Stanford, CA 94305
MEETING STARTS AT 8:30 AM IN Barnes/McDowell/Cranston
- Call to Order (welcoming remarks of regional representatives, if so desired)
- Spotlight Presentation on Diabetes.
MOVE TO McCaw Hall at 9:30 AM (Estimated time)
- Pledge of Allegiance.
- Roll Call.
[Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]
- Approval of minutes from December 6, 2005 ICOC meeting.
- Chairman’s Report.
- President’s Report
- Consideration of report from IP Task Force Subcommittee including but not limited to consideration of proposed Interim IP Policy for Non-Profit Organizations.
- Consideration of proposed Draft CIRM Medical and Ethical Standards/Regulations for Human Stem Cell Research.
- Consideration of report from Governance Subcommittee, including but not limited to consideration of policy for removal of Working Group members.
a. Contract and Interagency Agreement Update Summary
b. Contract and Interagency Agreement Spreadsheets
- Pending Litigation (Government Code section 11126, subdivision (e)): People’s Advocate v. Independent Citizens’ Oversight Committee, Alameda County Superior Court, Case No. HG05206766, consolidated with California Family Bioethics Council v. California Institute for Regenerative Medicine, Alameda County Superior Court, Case No. HG05235177; and Mary Scott Doe v. Robert Klein, et al., U.S. District Court, Central District, Case No. ED CV 05-00438.
- Public report of any action taken, if necessary, during closed session.
- Consideration of naming opportunity for CIRM training grant program.
- Informational report on plan/process for development of Scientific Strategic Plan.
- Consideration of scientific meeting: Assessing the Medical Risks of Human Oocyte Donation
- Consideration of joint venture with Public Library of Science and New York City Stem Cell Research Foundation.
- Informational report on proposed Interim Grant Administration Policy.
a. Introductory Summary of Proposed Interim Grant Adminstration Policy
- Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.
THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.
The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.
Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at firstname.lastname@example.org or 415-396-9100.
This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov.